hims glp-1 california & Hers Is Selling Copycat Weight-Loss Drugs. Here's How Digital pharmacy to offer weight-loss

While semaglutide is an excellent GLP-1 agonist, tirzepatides dual receptor activity appears to enhance satiety, improve insulin signaling, and reduce cravings in ways that translate into deeper weight reduction for many patients

Pomegranate Sometimes added for an antioxidant/superfood angle, not central to weight-loss claims

But physiology is foundational

Tirzepatide is technically a dual GIP and GLP-1 receptor agonist, but many patients group it with GLP-1 weight-loss injections because it affects the GLP-1 pathway

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity (SEMAMOOD) ID NCT07136714

Dulaglutide The AWARD-7 study assessed the efficacy and safety of dulaglutide in T2D patients with moderate-to-severe CKD (Tuttle et al., 2018)